IOL Chemicals Announces ₹495 Crore Pharma And Specialty Chemicals Expansion

Ibuprofen capacity to rise 50% to 18,000 MTPA for Rs350cr by Dec 2027 at 95% utilization, new 1,500m-tablet formulation CDMO for European anchors with Hungary GMP for Rs110cr, and Rs35cr dedicated specialty tolling plant, both to commercialize Q3 FY27. Context: first formulation vertical beyond APIs.